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ORIGINAL INVESTIGATION
Association of C2, a derivative of the radial 
artery pressure waveform, with new onset 
of type 2 diabetes mellitus: the MESA study
Daniel A. Duprez1* , Nkete I. Forbang2, Matthew A. Allison2,3, Carmen A. Peralta4, Steven Shea5 
and David R. Jacobs Jr.6
Abstract 
Background: Although microvascular dysfunction is known to result from diabetes, it might also lead to diabetes. 
Lower values of C2, a derivative of the radial artery pressure waveform, indicate microvascular dysfunction and predict 
hypertension and cardiovascular disease (CVD). We studied the association of C2 with incident diabetes in subjects 
free of overt CVD.
Methods: Among multi-ethnic participants (n = 5214), aged 45–84 years with no diabetes, C2 was derived from the 
radial artery pressure waveform. Incident diabetes (N = 651) was diagnosed as new fasting glucose ≥ 126 mg/dL or 
antidiabetic medicine over ~ 10 years. The relative incidence density (RID) for incident diabetes per standard deviation 
(SD) of C2 was studied during ~ 10 years follow-up using four levels of adjustment.
Results: Mean C2 at baseline was 4.58 ± 2.85 mL/mmHg × 100. The RID for incident diabetes per SD of C2 was 0.90 
(95% CI 0.82–0.99, P = 0.03). After adjustment for demographics plus body size, the corresponding RID was 0.81 (95% 
CI 0.73–0.89, P < 0.0001); body mass index (BMI) was the dominant covariate here. After adjustment for demographics 
plus cardiovascular risk factors, the RID was 0.98 (95% CI 0.89, 1.07, P = 0.63). After adjustment for all the parameters in 
the previous models, the RID was 0.87 (95% CI 0.78, 0.96, P = 0.006).
Conclusions: In a multi-ethnic sample free of overt CVD and diabetes at baseline, C2 predicted incident diabetes 
after adjustment for demographics, BMI and CVD risk factors. Differences in arterial blood pressure wave morphology 
may indicate a long-term risk trajectory for diabetes, independently of body size and the classical risk factors.
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Background
A large part of the pathogenesis in diabetes has been 
focused on insulin resistance and inflammation. Micro-
vascular disease resulting from diabetes has been 
described as leading to diabetic retinopathy, nephropa-
thy, and cardiomyopathy. For example Kannenkeril et al. 
[1] found microvascular changes in the retinal, renal, 
and systemic circulation in type 2 diabetes patients. Tut-
tolomundo et  al. [2] similar found changes in arterial 
stiffness in diabetic foot syndrome. Benitez-Aguirre et al. 
[3] found that studied greater arterial stiffness was asso-
ciated with later microvascular complications in type 
1 diabetes patients. During the last years it has been 
hypothesized that microvascular dysfunction might also 
be a precursor of development of diabetes, indepen-
dently of impaired fasting glucose [4, 5]. Microvascular 
dysfunction may occur as a consequence of endothelial 
dysfunction. Biomarkers of endothelial dysfunction were 
associated with a greater risk for diabetes [6–13]. A few 
studies demonstrated a higher incidence of type 2 diabe-
tes with smaller baseline retinal arteriolar diameter and 
arteriolo–venular ratio (AVR), while venular diameters 
were not significantly associated with incident diabetes 
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[14–17]. In addition, an attenuated endothelium-depend-
ent vasoreactivity response was significantly associated 
with incident diabetes in patients with hypertension [18].
Measurement of arterial stiffness is of scientific interest 
because it is a phenotype that is an early marker for car-
diovascular disease and is simple to implement clinically. 
It could also predict new onset diabetes, but the latter is 
still to be proven. During the last 2 decades, a derivative 
of the continuous radial artery blood pressure waveform, 
C2 which has been designated as either distal arterial 
compliance or small artery elasticity has been studied in 
the Multi-Ethnic Study of Atherosclerosis (MESA) [19–
21]. In MESA, C2 predicted new onset of arterial hyper-
tension, cardiovascular disease (myocardial infarction, 
coronary artery disease, stroke, heart failure, peripheral 
artery disease) and decline in renal function beyond the 
classical risk factors and inflammatory parameters [19–
21]. There is evidence that C2 may be considered as a 
marker for endothelial function/microvascular function 
[22]. Therefore we hypothesized that C2 may be a predic-
tor for future development of diabetes.
Methods
Study cohort
The MESA is a multi-center, prospective cohort designed 
to investigate prevalence, correlates, and progression 
of subclinical (asymptomatic) atherosclerosis and their 
associations with incident clinical events. A detailed 
description of the study design, recruitment methods, 
and examination components and data collections has 
been published [23]. In brief, participants included 6814 
men and women (age 45–84) of Caucasian, Hispanic, 
African–American and Chinese descent, free from clini-
cally manifest CVD at baseline. Signed informed consent 
was obtained for all participants, and institutional review 
board approval was obtained for all participating institu-
tions. We included 5214 participants free of diabetes and 
who had a C2 measurement at baseline and any follow-
up visit at which a diagnosis of diabetes could be made.
C2 measurement
At the baseline visit between 2000 and 2002, arterial 
waveforms were recorded for the entire cohort using 
the HDI/PulseWave CR-2000 (Hypertension Diagnos-
tics, Inc., Eagan, Minnesota). Details of this procedure 
have previously been published [24]. In brief, a solid state 
pressure transducer array (tonometer) was placed over 
the radial artery of the dominant arm to record the pulse 
contour. C2 is estimated by the device from the wave-
form modeled as a sinusoidal function dampened by a 
decaying exponential. An index estimated directly from 
the waveform is divided by systemic vascular resistance 
(SVR) to obtain C2. SVR is estimated as mean arterial 
blood pressure/cardiac output, and cardiac output is 
estimated from ejection time taken from the pulse wave-
form, heart rate, age, height. Higher C2 is considered to 
represent a more favorable cardiovascular status.
Risk factor assessment
Participants were given standardized questionnaires 
at baseline, which were used to obtain information on 
demographics, medical history, and smoking history. A 
medication inventory was also performed, and medica-
tions were grouped based on use to treat high blood pres-
sure, or elevated blood glucose. Height and weight were 
assessed using a standardized protocol and body mass 
index (BMI) was defined (kg/m2). Blood pressure was 
measured three times in the seated position with an auto-
mated oscillometric sphygmomanometer after at least 
5  min of rest. The average of the last 2 measurements 
was used. Standard measurements were taken for height 
and weight, and venous blood samples were obtained 
after a 12  h fast for measurements of total cholesterol, 
high-density lipoprotein (HDL) cholesterol, triglycerides 
and glucose. Physical activity (min/week in sports and 
dance) and TV watching (min/week) was assessed by a 
questionnaire.
Study endpoint: diabetes mellitus type 2
Among those free of diabetes at baseline according to 
self-reported clinical statement, baseline fasting plasma 
glucose < 126 mg/dL and no use of anti-diabetic medica-
tions at baseline, incident diabetes was defined as fast-
ing plasma glucose ≥ 126 mg/dL or start of anti-diabetic 
medications during the consecutive MESA follow-up 
visits. Note that it was not possible to distinguish inci-
dent type 1 from type 2 diabetes, but at MESA ages 
most diabetes would be type 2. Diabetes was identifiable 
only at clinic visits, which occurred at mean 1.64  years 
after baseline in 97.5% of participants, 3.20  years in 
93.5%, 4.84  years in 91.3% and 9.47  years in 75.6% of 
participants.
Statistical analysis
Descriptive statistics for the study cohort were sum-
marized by means (SD) and ranges for continuous vari-
ables, and frequencies for categorical variables following 
five C2 categories with equal intervals, but open-ended 
extremes (Table 1). Over a median follow-up of approxi-
mately 10  years, we computed the relative incidence 
density for new onset diabetes per standard deviation 
of C2 as a continuous variable and separately for each 
C2 category using Poisson regression using 4 levels of 
adjustment: model 1 adjusted for age, race, sex; model 2 
based on model 1 with further adjustment for body size 
(BMI and height; note that although height is part of 
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the mathematical definition of BMI, BMI and height are 
uncorrelated); model 3 based on model 1 with further 
adjustment for risk factors (heart rate, blood pressure and 
antihypertensive therapy, blood lipids and cholesterol 
lowering therapy, smoking, and physical activity); and 
model 4 including all of the above variables. The analy-
sis of C2 categories was also represented graphically. The 
study participants with borderline diabetes are at much 
higher risk for incident diabetes; this may differentially 
influence diabetes risk by C2 status. We therefore also 
examined the interaction with baseline impaired fasting 
glucose status and C2 in prediction of new onset diabe-
tes. Because C2 correlates with BMI, we calculated the 
Pearson correlations (sex-adjusted) with BMI at baseline. 
In a subset analysis, we also calculated the Pearson corre-
lations (sex-adjusted) with different contributing param-
eters to BMI, which were visceral fat (VAT), abdominal 
intermuscular adipose tissue (IMAT) and muscle lean 
volumes (LEAN). The latter measurements were obtained 
in a subset of participants by computed tomography 
at MESA exams 2 or 3 (means 1.64 and 3.20 years after 
MESA baseline, respectively) [25].
We considered P < 0.05 to be noteworthy in general 
screening of findings. Analyses were performed using 
PC-SAS, version 9.4 (SAS Institute, Cary, NC).
Results
Table 1 summarizes the characteristics of the study par-
ticipants following C2 categories. Mean C2 at baseline 
was 4.58 ± 2.85  mL/mm Hg × 100. C2 was lower with a 
higher age. Females had lower C2 than males. Height was 
associated with higher C2. Participants with a lower C2 
had higher systolic and diastolic blood pressure and they 
received more antihypertensive therapy. Participants 
with lower C2 had a more sedentary lifestyle. Study par-
ticipants with a higher C2 tended to have higher BMI.
Incident DM occurred in 651 participants during 
approximately 10 years follow-up. In Table 2, after adjust-
ment for demographics, the relative incidence density 
(RID) for incident DM per standard deviation of C2 was 
Table 1 Participant characteristics following  five C2 categories (with equal intervals with  open-ended extremes) 
in the Multi-Ethnic Study of Atherosclerosis, 2000–2002
HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, HTN Rx antihypertensive therapy, BMI body mass index, Chol cholesterol, HDL-chol high-
density cholesterol, Trig. triglycerides, Chol. Rx cholesterol lowering therapy, Phys. Activity physical activity, TV watching television watching
C2 categories (mL/mmHg × 100)
0.81 to < 2 (N = 797) 2 to < 4 (N = 1977) 4 to <6 (N = 1156) 6 to < 8 (N = 633) 8 to 20.74 
(N = 651)
Mean SD Mean SD Mean SD Mean SD Mean SD
C2 (mL/mmHg × 100) 1.64 0.26 2.90 0.58 4.91 0.57 6.91 0.58 10.44 2.06
Age (years) 68.1 9.1 64.0 9.7 59.2 9.3 57.0 9.2 54.1 7.9
White (column %) 33 40.2 43.3 45.7 50.8
Chinese 16.9 11.2 10.7 10.7 10.3
Black 25.5 27.9 25.2 24.8 17.4
Hispanic 24.6 20.7 20.8 18.8 21.5
Male 30.9 39.7 50.2 59.9 72.2
Height (cm) 161.2 8.6 164.8 9.4 167.9 9.4 170.2 9.4 173.4 9.2
HR (b/min) 63.4 9.9 62.4 9.5 63.0 9.2 61.7 8.3 60.7 8.1
SBP (mmHg) 138.3 22.3 129.0 21.0 121.8 18.1 115.8 16.2 112.7 14.1
DBP (mmHg) 74.1 10.7 72.1 10.4 71.9 10.1 70.3 9.6 70.5 9.6
HTN Rx (%) 40.9 33.7 27.7 19.1 14.3
BMI (kg/m2) 26.5 4.7 27.9 5.1 28.7 5.6 28.3 5.7 28.3 5.1
Former smoker (%) 31.2 36 37.6 36.8 39.6
Current smoker 12.5 13.8 12.2 11.5 10.9
Glucose (mg/dL) 91.1 10.7 89.6 10.3 89.7 10.7 88.2 10.6 88.1 9.8
Chol. (mg/dL) 197.1 35.0 196.8 35.3 194.0 34.2 193.3 34.7 190.1 33.7
HDL-C (mg/dL) 54.5 15.6 52.7 15.0 50.7 14.3 50.2 14.8 48.0 13.5
Trig. (mg/dL) 129.4 68.0 128.1 76.6 127.6 73.5 122.7 74.6 127.1 80.6
Chol. Rx (%) 19.3 15.2 14.4 12.3 8.9
Sport and dance phys. activ-
ity (min/week)
319.4 1069.2 351.5 964.4 341.5 806.8 432.6 1094.8 507.3 1179.6
TV watching (min/week) 932.6 635.9 903.2 639.4 842.6 613.0 789.9 638.2 721.9 540.1
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0.90 (95% CI 0.82–0.99, P = 0.03). After additional adjust-
ment beyond demographics for body size (namely, BMI 
and height) the corresponding RID was 0.81 (95% CI 
0.73–0.89, P < 0.0001); BMI was the dominant covariate 
in model 2. Omission of height from the model had little 
effect on the solution (data not shown). After adjustment 
for cardiovascular risk factors beyond demographics, the 
RID for incidence of DM for C2 was 0.98 (95% CI 0.89, 
1.07, P = 0.63). In model 4 in which there was an adjust-
ment for demographics, BMI, height and CV risk factors 
the RID for DM was 0.87 (95% CI 0.78, 0.96, P = 0.0.006). 
Figure 1 illustrates the incidence of DM by categories of 
C2. Whereas adjustment for CV risk factors tended to 
attenuate the association of C2 with incident diabetes 
(model 3), the strongest inverse association of C2 with 
incident diabetes occurred in model 2, adjusting for 
demographics, BMI and height; the association in model 
2 is accentuated compared to the one in model 1 with 
adjustment for demographics alone. There was no signifi-
cant interaction between impaired fasting glucose status 
and C2 in prediction of incident diabetes (P = 0.99). No 
race/ethnicity interaction with C2 was observed (data not 
shown).
In a subset of 1629 participants (Table  3) in whom 
IMAT, LEAN, and VAT were assessed at exams 2 or 3, 
although C2 at exam 1 was positively correlated with 
BMI. C2 was positively associated with muscle LEAN 
assessed 2–4  years later. BMI, IMAT and VAT form a 
triad with pairwise correlations of 0.57–0.61, P < 0.0001, 
but it is of note that although IMAT and LEAN have 
an inverse correlation (r = −  0.21, P < 0.0001), BMI and 
LEAN have a positive correlation (r = 0.29, P < 0.0001).
Table 2 Relative incidence density (RID) diabetes 
per standard deviation of C2 over approximately 10 years 
of follow-up
Model 1: adjusted for age, race, and sex; Model 2: Model 1 + BMI (body mass 
index) and height; Model 3: Model 1 + risk factors (heart rate, blood pressure 
and antihypertensive therapy, blood lipids and cholesterol lowering therapy, 
smoking, and physical activity); Model 4: All above variables
Incident diabetes P
N at risk RID 95% CI, lower 95% CI, upper
Model 1 5214 0.90 0.82 0.99 0.03
Model 2 5214 0.81 0.73 0.89 < 0.0001
Model 3 5167 0.98 0.89 1.07 0.63
Model 4 5167 0.87 0.78 0.96 0.006
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Fig. 1 Incident diabetes by categories of C2 at 4 levels of adjustment. 
Adjustment for body size (BMI and height) accentuated the 
association of C2 with diabetes, while adjustment for cardiovascular 
risk factors attenuated the association. BMI body mass index, risk 
factors: heart rate, blood pressure and antihypertensive therapy, 
blood lipids and cholesterol lowering therapy, smoking, physical 
activity
Table 3 Pearson correlations (sex-adjusted) in  1629 participants among  C2 and  several measures of  body mass index 
(BMI, at baseline = exam 1) and abdominal intermuscular adipose tissue (IMAT), muscle lean volume (LEAN) and visceral 
adipose tissue (VAT) obtained by  computed tomography at  MESA (mean 1.64 and  3.20  years after  MESA baseline, 
respectively = exam 2 and 3)
Although no participants had diagnosed diabetes at baseline (exam 1), some participants had a diagnosis of diabetes by the time of the CT assessment
Mean ± SD BMI IMAT LEAN VAT
C2 (mL/mmHg × 100) 4.6 ± 2.9 r 0.10 − 0.04 0.28 − 0.03
P 0.0001 0.14 <.0001 0.27
BMI (kg/m2) 27.8 ± 4.9 r 0.57 0.29 0.61
P < 0.0001 < 0.0001 < 0.0001
IMAT  (cm2) 2.5 ± 1.3 r − 0.21 0.60
P < 0.0001 < 0.0001
Muscle LEAN  (cm2) 13.4 ± 3.8 r 0.08
P 0.002
VAT  (cm2) 159.7 ± 82.1 r 1
P
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Discussion
In a multi-ethnic sample free of overt CVD and diabetes 
at baseline, a higher C2 predicted significantly lower inci-
dent diabetes after adjustment for demographics, BMI 
and CVD risk factors. As such, changes in arterial blood 
pressure wave morphology may manifest a long-term risk 
trajectory for diabetes independently of demographics, 
body size and the classical risk factors. This finding is in 
agreement with a finding in the Malmö Diet and Cancer 
cardiovascular cohort, for another measure of arterial 
stiffness, increased carotid-femoral pulse wave velocity, 
which was associated with increased incidence of diabe-
tes independent of other risk factors [26].
Among variables based on the pulse waveform, only 
C2 has been shown to be measure of the competence 
of the microcirculation [22]. Pulse wave velocity, which 
depends only on the arrival time of the waveform, is 
most studied. The assumption that connects pulse wave 
velocity to arterial stiffness is that a stiffer tube carries 
a pressure wave at higher velocity than a flexible tube. 
However, smaller arteries are not considered in this 
assumption. Other measures do depend on the shape of 
the waveform. Reflection magnitude [27] is based on the 
idea that when a forward pressure wave travels through 
a stiff artery, a reflection wave is formed, and pressure 
reflects back towards the origin of the forward wave. The 
augmentation index is computed after applying a trans-
fer function to approximate the central waveform. The 
augmentation index is the ratio of the second to the first 
peak in the central waveform. The second peak is thought 
to be higher in the presence of a reflection wave.
The measures C1 and C2 were initially derived from a 
third order Windkessel model of compliance in an elec-
trical circuit. The model assumes two capacitors, and 
when the capacitances C1  *  R and C2  *  R are divided 
by the systemic resistance, R, two systemic compliance 
measures, C1 and C2, result. The link to arterial stiffness 
is less direct in this case then in the case of the previ-
ously discussed measures. The proprietary owners of C1 
and C2 explored the solution to the Windkessel model 
and suggest that C1 strongly reflects the rapid decay of 
pressure during diastole, while C2 is a measure of the 
dampening oscillations as the waveform proceeds from 
late systole until mitral valve closure during diastole. The 
dampening of these oscillations could be the result of a 
superimposed reflection wave. C2 also has a microcircu-
latory dimension. Gilani et al. [22] measured C1 and C2 
in 10 healthy volunteers (3 male and 7 female) before and 
after inhibiting dilation of the small vessels by intra-arte-
rial infusion of the substituted arginine NG-nitro-l-ar-
ginine-methyl ester (l-NAME). C2 was decreased after 
inhibition, while C1 was not. The designation small artery 
elasticity for C2, which has been used by the proprietary 
owners of C2 and by us, may therefore be too specific. 
We prefer to use the more generic name C2, recognizing 
that C2 uniquely among waveform interpretations has 
been shown to relate to the microcirculation.
In our analyses, the association of C2 and incident 
diabetes is dominated among covariates by the associa-
tion of C2 with BMI, in which those with more favorable 
C2 had a higher BMI (BMI is therefore a negative con-
founder for the association of C2 and incident diabe-
tes) [28]. Although the physiologic basis for the positive 
association of C2 with BMI is not well understood, the 
situation may be complex [29]. Forbang et al. further dis-
cussed this anti-intuitive finding and confirmed that C2 
was positively associated with BMI, but also that C2 was 
inversely related to visceral adipose tissue once muscle 
mass was considered [25]. Clearly, BMI does not discrim-
inate well between peripheral and harmful fat. As shown 
in Table 3 of the present paper, this association with BMI 
may have as much to do with BMI as an indicator of lean 
muscle volume as with BMI as an indicator of body fat-
ness. In any case, BMI is a factor which is well known to 
be associated with higher incidence of diabetes, and its 
paradoxical association with better C2 must be consid-
ered in evaluating the association of C2 with diabetes.
Given the known association of C2 with microvascular 
function [22], the association we found between a low 
C2 and incident diabetes could have resulted from pre-
existing microvascular changes. While microvascular 
dysfunction may occur independently of dysglycemia, we 
acknowledge that the microvascular dysfunction repre-
sented by low C2 could be the result of dysglycemia even 
below the fasting glucose cutpoint for diabetes, although 
in our data baseline C2 and fasting glucose were only 
weakly correlated. Muris et al. found in their meta-analy-
sis that microvascular dysfunction (assessed using a vari-
ety of modalities) was associated with 10 to 49% higher 
incidence of type 2 diabetes [5]. This finding is consonant 
with the 50% higher diabetes incidence density, compar-
ing the lowest (least favorable) to highest (most favora-
ble) C2 categories in Fig. 1 in our study.
Strength of our study includes a representation of 
multiple ethnicities, both genders and a relatively large 
sample size. Prevalent CVD at baseline was an exclusion 
criterion. Our study also has the limitation that diabetes 
could only be diagnosed at 4 time points over the approx-
imate 10 year follow-up period, and some late-appearing 
diabetes diagnoses were missed, when diabetes onset was 
after the last attended clinic visit. Selective survival bias is 
also a possibility. The observational association between 
C2 and incidence DM cannot prove a causal relation-
ship and residual confounding is a possibility. A possible 
advantage to use the radial artery waveform for the cal-
culation of C2 is that the arterial waveform analysis can 
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also be used by applying mathematical algorithms to cal-
culate cardiac output non-invasively. A study by Maddali 
et  al. [30] used radial and femoral artery waveforms to 
calculate cardiac output; this measure correlated well 
with echocardiographic cardiac output measurements.
Conclusions
Our study demonstrated that C2, which is a deriva-
tive from the arterial blood pressure wave morphology, 
predicts new onset of diabetes independently from the 
classical risk factors. C2 provides information about 
microvascular function and therefore these findings 
add important information in the pathogenesis of dia-
betes that microvascular dysfunction is an important 
contributor for new onset of type 2 diabetes. Future 
studies are warranted to examine the role of new 
classes of anti-diabetic drugs, which a have a beneficial 
effect on the microcirculation and small vessels, to pre-
vent new development of type 2 diabetes.
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